NZ586662A - PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS - Google Patents
PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORSInfo
- Publication number
- NZ586662A NZ586662A NZ586662A NZ58666208A NZ586662A NZ 586662 A NZ586662 A NZ 586662A NZ 586662 A NZ586662 A NZ 586662A NZ 58666208 A NZ58666208 A NZ 58666208A NZ 586662 A NZ586662 A NZ 586662A
- Authority
- NZ
- New Zealand
- Prior art keywords
- chronic
- pyrazolo
- compounds
- useful
- leukaemia
- Prior art date
Links
- 229940121730 Janus kinase 2 inhibitor Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 abstract 2
- 108010024121 Janus Kinases Proteins 0.000 abstract 2
- 102000015617 Janus Kinases Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037398 BCR-ABL1 negative atypical chronic myeloid leukemia Diseases 0.000 abstract 1
- 208000032027 Essential Thrombocythemia Diseases 0.000 abstract 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 abstract 1
- 206010048643 Hypereosinophilic syndrome Diseases 0.000 abstract 1
- 208000035268 Mast Cell Activation disease Diseases 0.000 abstract 1
- 206010028561 Myeloid metaplasia Diseases 0.000 abstract 1
- 208000037538 Myelomonocytic Juvenile Leukemia Diseases 0.000 abstract 1
- 208000014767 Myeloproliferative disease Diseases 0.000 abstract 1
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 abstract 1
- 208000017733 acquired polycythemia vera Diseases 0.000 abstract 1
- 201000004892 atypical chronic myeloid leukemia Diseases 0.000 abstract 1
- 208000021668 chronic eosinophilic leukemia Diseases 0.000 abstract 1
- 201000010902 chronic myelomonocytic leukemia Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000005992 juvenile myelomonocytic leukemia Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 206010028537 myelofibrosis Diseases 0.000 abstract 1
- 208000037244 polycythemia vera Diseases 0.000 abstract 1
- 208000003476 primary myelofibrosis Diseases 0.000 abstract 1
- LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1482407P | 2007-12-19 | 2007-12-19 | |
| PCT/US2008/087362 WO2009085913A1 (en) | 2007-12-19 | 2008-12-18 | PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ586662A true NZ586662A (en) | 2012-08-31 |
Family
ID=40431839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ586662A NZ586662A (en) | 2007-12-19 | 2008-12-18 | PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8937064B2 (https=) |
| EP (1) | EP2252618A1 (https=) |
| JP (1) | JP5587206B2 (https=) |
| KR (1) | KR20100108390A (https=) |
| CN (1) | CN101932583A (https=) |
| AU (1) | AU2008343173A1 (https=) |
| CA (1) | CA2709710A1 (https=) |
| IL (1) | IL206466A0 (https=) |
| MX (1) | MX2010006748A (https=) |
| NZ (1) | NZ586662A (https=) |
| RU (1) | RU2010129928A (https=) |
| WO (1) | WO2009085913A1 (https=) |
| ZA (1) | ZA201004368B (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077999A1 (es) * | 2009-09-02 | 2011-10-05 | Vifor Int Ag | Antagonistas de pirimidin y triazin-hepcidina |
| EP2338888A1 (en) * | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
| UY33213A (es) * | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
| WO2012044561A2 (en) * | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | 2-alkoxy pyrimidine pde10 inhibitors |
| EP2463289A1 (en) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors |
| EP2734205B1 (en) | 2011-07-21 | 2018-03-21 | Tolero Pharmaceuticals, Inc. | Heterocyclic protein kinase inhibitors |
| EP2554544A1 (en) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1h)-one derivatives as jak inhibitors |
| EP4556010A3 (en) | 2011-11-30 | 2025-07-23 | Emory University | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| CN102887858B (zh) * | 2012-09-07 | 2014-11-19 | 苏州康润医药有限公司 | 3-氯-5-氨基-1h-吡唑-4-甲酸乙酯的合成方法 |
| CN103073549A (zh) * | 2012-09-07 | 2013-05-01 | 苏州康润医药有限公司 | 3-溴吡唑啉[1,5-α]吡嘧啶-2-甲酸的合成工艺 |
| SI2941432T1 (en) * | 2012-12-07 | 2018-07-31 | Vertex Pharmaceuticals Incorporated | 2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR |
| DK3077397T3 (da) | 2013-12-06 | 2019-12-16 | Vertex Pharma | 2-amino-6-fluor-n-[5-fluor-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamidforbindelse anvendelig som atr-kinase-inhibitor, dens fremstilling, forskellige faste former og radiomarkerede derivater deraf |
| WO2017013270A1 (en) | 2015-07-23 | 2017-01-26 | Universite De Strasbourg | Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy |
| HK1258570A1 (zh) | 2015-09-30 | 2019-11-15 | Vertex Pharmaceuticals Inc. | 使用dna损伤剂及atr抑制剂的组合治疗癌症的方法 |
| CN117838695A (zh) | 2018-04-13 | 2024-04-09 | 住友制药肿瘤公司 | 用于治疗骨髓增殖性肿瘤和与癌症相关的纤维化的pim激酶抑制剂 |
| NZ778055A (en) | 2019-02-12 | 2025-11-28 | Sumitomo Pharma America Inc | Formulations comprising heterocyclic protein kinase inhibitors |
| CN114761013A (zh) | 2019-09-27 | 2022-07-15 | 迪斯克医药公司 | 治疗骨髓纤维化和相关病症的方法 |
| WO2021231798A1 (en) | 2020-05-13 | 2021-11-18 | Disc Medicine, Inc. | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| EP4598539A2 (en) * | 2022-10-04 | 2025-08-13 | Children's Hospital Medical Center | Multi-cyclic irak and flt3 inhibiting compounds and uses thereof |
| EP4611753A1 (en) | 2022-10-31 | 2025-09-10 | Sumitomo Pharma America, Inc. | Pim1 inhibitor for treating myeloproliferative neoplasms |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| IL127566A0 (en) | 1996-08-28 | 1999-10-28 | Pfizer | Substituted 6,5-hetero- bicyclic derivatives |
| CA2291709A1 (en) | 1997-05-30 | 1998-12-03 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
| US6245759B1 (en) | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7713989B2 (en) * | 2000-04-27 | 2010-05-11 | Dow Robert L | Glucocorticoid receptor modulators |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| DK1532145T3 (da) | 2002-08-02 | 2007-01-15 | Vertex Pharma | Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3 |
| US7550470B2 (en) | 2002-12-11 | 2009-06-23 | Merck & Co. Inc. | Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors |
| US7226919B2 (en) * | 2002-12-18 | 2007-06-05 | Vertex Pharmaceuticals Inc. | Compositions useful as inhibitors of protein kinases |
| NZ546058A (en) * | 2004-01-12 | 2010-09-30 | Ym Biosciences Australia Pty | Benzimidazole and other fused ring derivatives as selective janus kinase inhibitors |
| TWI372624B (en) * | 2004-03-30 | 2012-09-21 | Vertex Pharma | Azaindoles useful as inhibitors of jak and other protein kinases |
| GB0519957D0 (en) | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
| ATE482213T1 (de) * | 2004-11-04 | 2010-10-15 | Vertex Pharma | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine |
| WO2007017678A1 (en) | 2005-08-09 | 2007-02-15 | Eirx Therapeutics Limited | Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them |
| ZA200802685B (en) * | 2005-09-30 | 2009-10-28 | Vertex Pharma | Deazapurines useful as inhibitors of janus kinases |
| CN101679409B (zh) * | 2006-12-22 | 2014-11-26 | Astex治疗学有限公司 | 双环杂环衍生化合物、其医药组合物和其用途 |
| ATE526328T1 (de) * | 2007-03-09 | 2011-10-15 | Vertex Pharma | Als inhibitoren von proteinkinasen geeignete aminopyrimidine |
| CN101790532B (zh) | 2007-07-31 | 2013-11-20 | 沃泰克斯药物股份有限公司 | 5-氟-1H-吡唑并[3，4-b]吡啶-3-胺及其衍生物的制备方法 |
-
2008
- 2008-12-18 NZ NZ586662A patent/NZ586662A/xx not_active IP Right Cessation
- 2008-12-18 JP JP2010539781A patent/JP5587206B2/ja not_active Expired - Fee Related
- 2008-12-18 RU RU2010129928/04A patent/RU2010129928A/ru not_active Application Discontinuation
- 2008-12-18 AU AU2008343173A patent/AU2008343173A1/en not_active Abandoned
- 2008-12-18 CA CA2709710A patent/CA2709710A1/en not_active Abandoned
- 2008-12-18 KR KR1020107015961A patent/KR20100108390A/ko not_active Withdrawn
- 2008-12-18 WO PCT/US2008/087362 patent/WO2009085913A1/en not_active Ceased
- 2008-12-18 EP EP08867722A patent/EP2252618A1/en not_active Withdrawn
- 2008-12-18 MX MX2010006748A patent/MX2010006748A/es unknown
- 2008-12-18 CN CN2008801260776A patent/CN101932583A/zh active Pending
-
2010
- 2010-06-17 US US12/817,785 patent/US8937064B2/en not_active Expired - Fee Related
- 2010-06-17 IL IL206466A patent/IL206466A0/en unknown
- 2010-06-21 ZA ZA2010/04368A patent/ZA201004368B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2709710A1 (en) | 2009-07-09 |
| MX2010006748A (es) | 2010-08-18 |
| JP5587206B2 (ja) | 2014-09-10 |
| EP2252618A1 (en) | 2010-11-24 |
| RU2010129928A (ru) | 2012-01-27 |
| AU2008343173A1 (en) | 2009-07-09 |
| WO2009085913A1 (en) | 2009-07-09 |
| US8937064B2 (en) | 2015-01-20 |
| JP2011507881A (ja) | 2011-03-10 |
| IL206466A0 (en) | 2010-12-30 |
| CN101932583A (zh) | 2010-12-29 |
| ZA201004368B (en) | 2013-01-30 |
| US20110118255A1 (en) | 2011-05-19 |
| KR20100108390A (ko) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ586662A (en) | PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS | |
| HUS2000006I1 (hu) | Szubsztituált pirazolo[1,5-a]pirimidin vegyületek mint TRK kináz inhibitorok | |
| NZ738778A (en) | Pyrazolopyrimidine jak inhibitor compounds and methods | |
| CL2009000255A1 (es) | Compuestos derivados de pirrolo [2,3-d] pirimidinas, con actividad inhibidora de cinasa jak1, jak2 y jak3; composicion farmaceutica; utiles en el tratamiento de enfermedades proliferativas, rechazo a trasplantes, lupus eritematoso, esclerosis multiple, artritis reumatoide, entre otras. | |
| PH12016502060A1 (en) | Processes for preparing jak inhibitors and related intermediate compounds | |
| CL2011002956A1 (es) | Compuestos derivados de pirrolo[2,3-d]pirimidina, inhibidores de la quinasa janus (jak1); composicion farmaceutica; y uso para el tratamiento de una enfermedad autoinmune, cancer, trastorno mieloproliferativo, una enfermedad inflamatoria o rechazo de trasplante de organos. | |
| IL217414A0 (en) | SUBSTITUTED PYRAZOLO[1, 5-a] PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | |
| PE20080071A1 (es) | PIRAZOLO[1,5-a]PIRIMIDINAS | |
| CL2012000795A1 (es) | Compuestos derivados de pirrolo[2,3-d]pirimidina, inhibidores de la quinasa janus (jak); composicion farmaceutica que comprnde a uno de dichos compuestos; y su uso para la preparacion de medicamentos utiles en el tratamiento de alzheimer, cancer, artritis, leucemia, diabetes, enfermedades inflamatorias y autoinmunes, entre otras. | |
| ES2898938T3 (es) | Compuestos de heteroarilpiridona y aza-piridona como inhibidores de la actividad Btk | |
| CL2008001862A1 (es) | Forma cristalina i, iii e hidratada de 6-{difluoro-[6-(1-metil-1h-pirazol-4-il)[1,2,4]triazolo[4,3-b]piridazin-3-il]metil}quinolina; composicion farmaceutica que las comprende; y su uso para prevenir o tratar un un trastorno proliferativo celular. | |
| WO2007147109A3 (en) | Novel compounds | |
| TW200726770A (en) | Organic compounds | |
| WO2007147104A3 (en) | Novel compounds | |
| HK1212334A1 (en) | Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]-triazolo[1,5-c]pyrimidine from 4-chloro-2,5-dimethoxypyrimidine | |
| UY29262A1 (es) | 7-amino-6-heteroaril-1,2,4-triazolo(1,5-a)pirimidinas y su uso para el combate de hongos daninos | |
| TW200738720A (en) | 7-Amino-6-heteroaryl-1,2,4-triazolo[1,5-a]pyrimidine compounds and their use for controlling harmful fungi | |
| UY29670A1 (es) | Compuestos de 7-amino-6heteroaril-1,2,4-triazolo(1,5-a)primidina y su uso para el combate de hongos daninos.- | |
| CL2009000477A1 (es) | Compuestos derivados de heterociclo espiro bicíclico o heterocíclico bicíclico, puenteado de pirazolo[1,5-a]pirimidinas, métodos para su preparación y usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Patent lapsed | ||
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 3155030, VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MASSACHUSETTS 02210, US Effective date: 20150127 |